5ak0: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Human PFKFB3 in complex with an indole inhibitor 6== | ==Human PFKFB3 in complex with an indole inhibitor 6== | ||
<StructureSection load='5ak0' size='340' side='right' caption='[[5ak0]], [[Resolution|resolution]] 2.03Å' scene=''> | <StructureSection load='5ak0' size='340' side='right'caption='[[5ak0]], [[Resolution|resolution]] 2.03Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5ak0]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AK0 OCA]. For a <b>guided tour on the structure components</b> use [ | <table><tr><td colspan='2'>[[5ak0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AK0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5AK0 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=8V1:(2S)-N-[4-[1-METHYL-3-(1-METHYLPYRAZOL-4-YL)INDOL-5-YL]OXYPHENYL]PYRROLIDINE-2-CARBOXAMIDE'>8V1</scene>, <scene name='pdbligand=F6P:FRUCTOSE-6-PHOSPHATE'>F6P</scene>, <scene name='pdbligand=PHS:PHOSPHONIC+ACID'>PHS</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.03Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=8V1:(2S)-N-[4-[1-METHYL-3-(1-METHYLPYRAZOL-4-YL)INDOL-5-YL]OXYPHENYL]PYRROLIDINE-2-CARBOXAMIDE'>8V1</scene>, <scene name='pdbligand=F6P:FRUCTOSE-6-PHOSPHATE'>F6P</scene>, <scene name='pdbligand=PHS:PHOSPHONIC+ACID'>PHS</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ak0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ak0 OCA], [https://pdbe.org/5ak0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ak0 RCSB], [https://www.ebi.ac.uk/pdbsum/5ak0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ak0 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/F263_HUMAN F263_HUMAN] Synthesis and degradation of fructose 2,6-bisphosphate. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 17: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
<div class="pdbe-citations 5ak0" style="background-color:#fffaf0;"></div> | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Boyd | [[Category: Homo sapiens]] | ||
[[Category: Brookfield | [[Category: Large Structures]] | ||
[[Category: Critchlow | [[Category: Boyd S]] | ||
[[Category: Cumming | [[Category: Brookfield JL]] | ||
[[Category: Curtis | [[Category: Critchlow SE]] | ||
[[Category: Debreczeni | [[Category: Cumming IA]] | ||
[[Category: Degorce | [[Category: Curtis NJ]] | ||
[[Category: Donald | [[Category: Debreczeni JE]] | ||
[[Category: Evans | [[Category: Degorce SL]] | ||
[[Category: Groombridge | [[Category: Donald C]] | ||
[[Category: Hopcroft | [[Category: Evans NJ]] | ||
[[Category: Jones | [[Category: Groombridge S]] | ||
[[Category: Kettle | [[Category: Hopcroft P]] | ||
[[Category: Lamont | [[Category: Jones NP]] | ||
[[Category: Lewis | [[Category: Kettle JG]] | ||
[[Category: MacFaull | [[Category: Lamont S]] | ||
[[Category: McLoughlin | [[Category: Lewis HJ]] | ||
[[Category: Rigoreau | [[Category: MacFaull P]] | ||
[[Category: Smith | [[Category: McLoughlin SB]] | ||
[[Category: St-Gallay | [[Category: Rigoreau LJM]] | ||
[[Category: Stock | [[Category: Smith JM]] | ||
[[Category: Wheatley | [[Category: St-Gallay S]] | ||
[[Category: Wingfield | [[Category: Stock JK]] | ||
[[Category: Winter | [[Category: Wheatley ER]] | ||
[[Category: Wingfield J]] | |||
[[Category: Winter J]] | |||
Latest revision as of 11:41, 9 May 2024
Human PFKFB3 in complex with an indole inhibitor 6
| ||||||||||||